Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.

Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16.

PMID:
21161509
2.

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD; CaMos Research Group.

Osteoporos Int. 2011 Mar;22(3):829-37. doi: 10.1007/s00198-010-1465-1. Epub 2010 Dec 16.

3.

Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts.

Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley DA, Ioannidis G, Josse RG, Kovacs CS, Towheed T, Kaiser S, Olszynski WP, Prior JC, Jamal S, Kreiger N, Goltzman D; Canadian Multicentre Osteoporosis Study Research Group.

Osteoporos Int. 2011 Jun;22(6):1873-83. doi: 10.1007/s00198-010-1445-5. Epub 2010 Oct 22.

4.

Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):839-47. doi: 10.1007/s00198-010-1461-5. Epub 2010 Oct 20.

PMID:
20959961
5.

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M; American Society for Bone and Mineral Research.

J Bone Miner Res. 2010 Nov;25(11):2267-94. doi: 10.1002/jbmr.253. Erratum in: J Bone Miner Res. 2011 Aug;26(8):1987.

6.

Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.

Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V.

BMJ. 2010 Sep 1;341:c4444. doi: 10.1136/bmj.c4444.

7.

Exposure to oral bisphosphonates and risk of esophageal cancer.

Cardwell CR, Abnet CC, Cantwell MM, Murray LJ.

JAMA. 2010 Aug 11;304(6):657-63. doi: 10.1001/jama.2010.1098.

8.

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR.

BMJ. 2010 Jul 29;341:c3691. doi: 10.1136/bmj.c3691. Review.

9.

Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary).

Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD; Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada.

CMAJ. 2010 Sep 7;182(12):1315-9. doi: 10.1503/cmaj.091062. Epub 2010 Jul 12. Review. No abstract available.

10.

Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Bone Miner Res. 2010 Nov;25(11):2350-8. doi: 10.1002/jbmr.123.

11.

Effect of osteoporosis treatment on mortality: a meta-analysis.

Bolland MJ, Grey AB, Gamble GD, Reid IR.

J Clin Endocrinol Metab. 2010 Mar;95(3):1174-81. doi: 10.1210/jc.2009-0852. Epub 2010 Jan 15.

PMID:
20080842
12.

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.

Hines SL, Sloan JA, Atherton PJ, Perez EA, Dakhil SR, Johnson DB, Reddy PS, Dalton RJ, Mattar BI, Loprinzi CL.

Breast. 2010 Apr;19(2):92-6. doi: 10.1016/j.breast.2009.12.001. Epub 2010 Jan 15.

13.

Prevention of osteoporosis-related fractures among postmenopausal women and older men.

Rahmani P, Morin S.

CMAJ. 2009 Nov 24;181(11):815-20. doi: 10.1503/cmaj.080709. Epub 2009 Oct 19. Review. No abstract available.

14.

Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).

Langdahl BL, Rajzbaum G, Jakob F, Karras D, Ljunggren O, Lems WF, Fahrleitner-Pammer A, Walsh JB, Barker C, Kutahov A, Marin F.

Calcif Tissue Int. 2009 Dec;85(6):484-93. doi: 10.1007/s00223-009-9299-6. Epub 2009 Oct 13.

15.

Effects of exercise programmes on quality of life in osteoporotic and osteopenic postmenopausal women: a systematic review and meta-analysis.

Li WC, Chen YC, Yang RS, Tsauo JY.

Clin Rehabil. 2009 Oct;23(10):888-96. doi: 10.1177/0269215509339002. Epub 2009 Aug 28. Review.

PMID:
19717503
16.

Denosumab in men receiving androgen-deprivation therapy for prostate cancer.

Smith MR, Egerdie B, Hernández Toriz N, Feldman R, Tammela TL, Saad F, Heracek J, Szwedowski M, Ke C, Kupic A, Leder BZ, Goessl C; Denosumab HALT Prostate Cancer Study Group.

N Engl J Med. 2009 Aug 20;361(8):745-55. doi: 10.1056/NEJMoa0809003. Epub 2009 Aug 11.

17.

Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C; FREEDOM Trial.

N Engl J Med. 2009 Aug 20;361(8):756-65. doi: 10.1056/NEJMoa0809493. Epub 2009 Aug 11. Erratum in: N Engl J Med. 2009 Nov 5;361(19):1914.

18.

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study.

Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD.

CMAJ. 2009 Sep 1;181(5):265-71. doi: 10.1503/cmaj.081720. Epub 2009 Aug 4.

19.

Simplified system for absolute fracture risk assessment: clinical validation in Canadian women.

Leslie WD, Tsang JF, Lix LM; Manitoba Bone Density Program.

J Bone Miner Res. 2009 Feb;24(2):353-60. doi: 10.1359/jbmr.081012.

20.

Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials.

de Kam D, Smulders E, Weerdesteyn V, Smits-Engelsman BC.

Osteoporos Int. 2009 Dec;20(12):2111-25. doi: 10.1007/s00198-009-0938-6. Epub 2009 May 7. Review.

PMID:
19421702

Supplemental Content

Support Center